232 related articles for article (PubMed ID: 19095437)
1. Individual patient data analysis to assess modifications to the RECIST criteria.
Bogaerts J; Ford R; Sargent D; Schwartz LH; Rubinstein L; Lacombe D; Eisenhauer E; Verweij J; Therasse P;
Eur J Cancer; 2009 Jan; 45(2):248-60. PubMed ID: 19095437
[TBL] [Abstract][Full Text] [Related]
2. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
Mazumdar M; Smith A; Schwartz LH
J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
[TBL] [Abstract][Full Text] [Related]
3. RECIST revisited: a review of validation studies on tumour assessment.
Therasse P; Eisenhauer EA; Verweij J
Eur J Cancer; 2006 May; 42(8):1031-9. PubMed ID: 16616487
[TBL] [Abstract][Full Text] [Related]
4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eisenhauer EA; Therasse P; Bogaerts J; Schwartz LH; Sargent D; Ford R; Dancey J; Arbuck S; Gwyther S; Mooney M; Rubinstein L; Shankar L; Dodd L; Kaplan R; Lacombe D; Verweij J
Eur J Cancer; 2009 Jan; 45(2):228-47. PubMed ID: 19097774
[TBL] [Abstract][Full Text] [Related]
5. [New guidelines to evaluate the response to treatment "RECIST"].
Sasaki T
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2179-84. PubMed ID: 11142160
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the value of confirming responses in clinical trials in oncology.
Perez-Gracia JL; Muñoz M; Williams G; Wu J; Carrasco E; Garcia-Ribas I; Peiro A; Lopez-Picazo JM; Gurpide A; Chopitea A; Martín-Algarra S; García-Foncillas J; Blatter J
Eur J Cancer; 2005 Jul; 41(11):1528-32. PubMed ID: 16026690
[TBL] [Abstract][Full Text] [Related]
7. [New guidelines to evaluate the response to treatment in solid tumors].
Duffaud F; Therasse P
Bull Cancer; 2000 Dec; 87(12):881-6. PubMed ID: 11174117
[TBL] [Abstract][Full Text] [Related]
8. Response evaluation criteria in solid tumors (RECIST): new guidelines.
Tsuchida Y; Therasse P
Med Pediatr Oncol; 2001 Jul; 37(1):1-3. PubMed ID: 11466715
[No Abstract] [Full Text] [Related]
9. Selection of response criteria for clinical trials of sarcoma treatment.
Schuetze SM; Baker LH; Benjamin RS; Canetta R
Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
[TBL] [Abstract][Full Text] [Related]
10. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
[TBL] [Abstract][Full Text] [Related]
11. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
Forner A; Ayuso C; Varela M; Rimola J; Hessheimer AJ; de Lope CR; Reig M; Bianchi L; Llovet JM; Bruix J
Cancer; 2009 Feb; 115(3):616-23. PubMed ID: 19117042
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
14. [A summary report of response evaluation criteria in solid tumors (RECIST criteria)].
Kusaba H; Saijo N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):1-5. PubMed ID: 10660728
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
Ohorodnyk P; Eisenhauer EA; Booth CM
Eur J Cancer; 2009 Sep; 45(13):2249-52. PubMed ID: 19545996
[TBL] [Abstract][Full Text] [Related]
16. Tumour growth rates and RECIST criteria in early drug development.
Gomez-Roca C; Koscielny S; Ribrag V; Dromain C; Marzouk I; Bidault F; Bahleda R; Ferté C; Massard C; Soria JC
Eur J Cancer; 2011 Nov; 47(17):2512-6. PubMed ID: 21763126
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of tumour response to cancer treatment: morphologic imaging role].
Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
[TBL] [Abstract][Full Text] [Related]
18. Open retropubic colposuspension for urinary incontinence in women: a short version Cochrane review.
Lapitan MC; Cody JD; Grant A
Neurourol Urodyn; 2009; 28(6):472-80. PubMed ID: 19591206
[TBL] [Abstract][Full Text] [Related]
19. Update in methodology and conduct of cancer clinical trials.
Therasse P; Eisenhauer EA; Buyse M
Eur J Cancer; 2006 Jul; 42(10):1322-30. PubMed ID: 16737813
[TBL] [Abstract][Full Text] [Related]
20. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
